- Investing Ideas
- /
- Global High Insider Buying
Global High Insider Buying
Results
2638
0 new
Stocks with high levels of insider buying the past 3 months and good analyst coverage.
2,638 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
JNJ | US$152.15 | -0.5% | -2.3% | US$366.3b | US$168.64 | PE26x | E8.4% | 3.3% | Pharmaceuticals & Biotech | ||
AZN | UK£113.44 | 1.5% | 9.5% | UK£175.9b | UK£138.93 | PE33.6x | E16.9% | 2.0% | Pharmaceuticals & Biotech | ||
HSBA | UK£8.46 | 2.6% | 36.6% | UK£148.7b | UK£8.67 | PB1x | E-1.3% | 5.8% | Banks | ||
CBA | AU$158.13 | -0.3% | 36.9% | AU$268.4b | AU$101.65 | PB3.6x | E4.3% | 2.9% | Banks | ||
LOW | US$260.04 | -3.1% | 19.3% | US$146.8b | US$282.24 | PE21.5x | E5.7% | 1.8% | Retail | ||
COP | US$98.83 | -3.8% | -10.1% | US$127.8b | US$131.97 | PE12.9x | E1.6% | 3.8% | Energy | ||
BHP | AU$39.24 | -0.2% | -15.5% | AU$202.6b | AU$44.32 | PE15.7x | E6.4% | 6.0% | Materials | ||
TD | CA$82.91 | 0.3% | 3.5% | CA$145.1b | CA$86.47 | PB1.3x | E11.5% | 5.1% | Banks | ||
INVE A | SEK 316.50 | 2.1% | 29.2% | SEK 969.1b | SEK 331.50 | PE8.6x | E-48.3% | 1.6% | Diversified Financials | ||
BP. | UK£4.23 | 1.3% | -7.0% | UK£66.3b | UK£4.81 | PE30.2x | E23.6% | 5.8% | Energy | ||
ATCO A | SEK 186.20 | -0.4% | 11.5% | SEK 875.0b | SEK 188.52 | PE30.5x | E6.9% | 1.6% | Capital Goods | ||
ITW | US$259.16 | -2.0% | 1.9% | US$76.5b | US$264.31 | PE22.2x | E1.1% | 2.3% | Capital Goods | ||
NAB | AU$39.22 | -0.5% | 21.3% | AU$123.0b | AU$34.11 | PB2x | E2.0% | 4.3% | Banks | ||
1299 | HK$53.45 | -0.6% | -11.3% | HK$580.2b | HK$93.05 | PE15.2x | E13.7% | 3.1% | Insurance | ||
BREN | Rp9,025.00 | -6.0% | 82.3% | Rp1207.4t | n/a | PE679.6x | n/a | 0.04% | Utilities | ||
WBC | AU$33.16 | 0.4% | 37.1% | AU$115.6b | AU$28.90 | PB1.6x | E-0.007% | 4.6% | Banks | ||
GSK | UK£14.05 | 0.2% | -15.5% | UK£57.3b | UK£17.94 | PE22.8x | E20.8% | 4.1% | Pharmaceuticals & Biotech | ||
CRH | US$99.03 | 0% | 36.4% | US$67.0b | US$114.33 | PE19.4x | E9.6% | 1.4% | Materials | ||
DGE | UK£24.19 | -3.0% | -18.9% | UK£53.8b | UK£26.65 | PE17.2x | E5.0% | 3.4% | Food, Beverage & Tobacco | ||
CNR | CA$151.82 | -1.0% | -11.3% | CA$95.4b | CA$169.45 | PE21.4x | E8.4% | 2.2% | Transportation | ||
SPG | US$173.86 | -1.6% | 27.1% | US$65.3b | US$186.53 | PB21.2x | E0.4% | 4.8% | Real Estate | ||
FDX | US$264.87 | -5.9% | 11.1% | US$63.8b | US$323.52 | PE16.4x | E12.9% | 2.1% | Transportation | ||
KMI | US$27.48 | 0.07% | 64.8% | US$61.1b | US$29.59 | PE23.4x | E9.3% | 4.2% | Energy | ||
CPG | UK£27.91 | 2.9% | 29.7% | UK£47.4b | UK£27.34 | PE41.8x | E14.6% | 1.7% | Consumer Services |